Neurofibromatosis (NF): Diagnosis, Management and Health Impact


Jeremy Murphy (Editor)

Series: Neurology – Laboratory and Clinical Research Developments
BISAC: MED056000

Neurofibromatosis 1 (NF1) is a neurocutaneous disorder with a heterogenous presentation affecting 1 in 2500 to 1 in 3000 births. Our understanding of the pathogenesis of NF1 has increased dramatically since the discovery of the NF1 gene in 1990 and the role its product, neurofibromin, plays in tumor suppression. This book provides new research on the diagnosis, management and health impacts of NF. (Imprint: Nova Biomedical)

Table of Contents

Table of Contents


Chapter 1. Oral Manifestations in Neurofibromatosis 1
Karin Soares Cunha, Eloá Borges Luna, Flávia Lima, and Rafaela Elvira Rozza-de-Menezes (Graduate Program in Pathology, School of Medicine, Universidade Federal Fluminense, Niterói, Brazil, and others)

Chapter 2. Congenital Pseudarthrosis of the Tibia in Neurofibromatosis Type 1
Muhammad B. Tariq, Allen Xu, Lynn Daboul, and Richard A. Prayson (Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA, and others)

Chapter 3. Social-Emotional Functioning and Quality of Life in Neurofibromatosis 1
Daniel P. Sexton, Rebecca L. Achey and Richard A. Prayson (Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA)

Chapter 4. Health Implications of Cognitive Impairment in Neurofibromatosis Type 1
Anne Song, Briana C. Prager, Vaidehi Mahadev, and Richard A. Prayson (Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, Cleveland, OH, USA, and others)

Chapter 5. Survey of Clinically Applicable Therapeutic Agents and Modalities for Neurofibromatosis Type 1 Patient Skin Lesions
Juichiro Nakayama (General Medical Research Center, Fukuoka University Faculty of Medicine, Jonan–ku, Fukuoka, Japan)


Publish with Nova Science Publishers

We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!